ArticleBiomedical reports2025
Impact of the ATM/Chk2 pathway and cell cycle phase on radiation-induced senescence in A549 human lung cancer cells.
Article in Biomedical reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Ubiquitination of DDX21 by HERC2 induces a dormancy-like phenotype via the NUCKS1-p21/p27 axis to promote radio-resistance in colorectal cancer cells.Cell death & disease · 2026Article
- Role of the Super-Enhancer Component Bromodomain Protein 4 in the Radiation Response of Human Head and Neck Squamous Cell Carcinoma Cells.Current issues in molecular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell senescence is a state of stable proliferation arrest characterized by morphological changes and high senescence-associated β-galactosidase (SA-β-gal) activity. Inducing senescence in cancer cells is beneficial for cancer therapy due to proliferation arrest, however, the mechanisms underlying this process remain insufficiently understood. Therefore, the present study investigated the mechanisms of radiation-induced cellular senescence in A549 human lung cancer cells, focusing on the DNA damage response and cell cycle regulation. Cellular senescence was estimated by activity of SA-β-gal, and cell cycle was analyzed by propidium iodide staining using a flow cytometer. Cell cycle synchronization was performed by the double thymine block method. First, the roles of ataxia telangiectasia mutated (ATM) and ataxia telangiectasia mutated and Rad3-related (ATR), which are important factors for DNA damages response, in radiation-induced cellular senescence were investigated. ATM/ATR inhibitors suppressed radiation-induced G2/M phase arrest and decreased the percentage of senescent cells with high SA-β-gal activity, implying that G2/M arrest was associated with radiation-induced senescence. However, an analysis using inhibitors of checkpoint kinase 1 (Chk1) and Chk2, which function downstream of ATR and ATM, respectively, revealed that the Chk2, but not the Chk1, pathway was involved in radiation-induced senescence. To enhance radiation-induced senescence, radiation was combined with olaparib treatment, an inhibitor of DNA single-strand break repair. Olaparib increased the number of radiation-induced senescent cells. Additionally, cell cycle synchronization experiments revealed that irradiation of cells in S or G2/M phase resulted in higher senescent cell counts than irradiation in G1 phase. Taken together, the present results demonstrated that the ATM/Chk2 pathway and the DNA content are involved in the radiation-induced senescence of A549 cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.